- Home
- BDC vs CRNX Comparison
BDC vs CRNX Comparison
Compare BDC & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDC
- CRNX
- Stock Information
- Founded
- BDC 1902
- CRNX 2008
- Country
- BDC United States
- CRNX United States
- Employees
- BDC N/A
- CRNX N/A
- Industry
- BDC Telecommunications Equipment
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- BDC Telecommunications
- CRNX Health Care
- Exchange
- BDC Nasdaq
- CRNX Nasdaq
- Market Cap
- BDC 4.6B
- CRNX 5.2B
- IPO Year
- BDC 1993
- CRNX 2018
- Fundamental
- Price
- BDC $111.57
- CRNX $37.46
- Analyst Decision
- BDC Strong Buy
- CRNX Strong Buy
- Analyst Count
- BDC 5
- CRNX 12
- Target Price
- BDC $130.20
- CRNX $72.64
- AVG Volume (30 Days)
- BDC 260.7K
- CRNX 710.8K
- Earning Date
- BDC 02-06-2025
- CRNX 02-27-2025
- Dividend Yield
- BDC 0.18%
- CRNX N/A
- EPS Growth
- BDC N/A
- CRNX N/A
- EPS
- BDC 4.80
- CRNX N/A
- Revenue
- BDC $2,460,979,000.00
- CRNX $1,038,999.00
- Revenue This Year
- BDC $12.52
- CRNX N/A
- Revenue Next Year
- BDC $4.98
- CRNX $206.01
- P/E Ratio
- BDC $23.17
- CRNX N/A
- Revenue Growth
- BDC N/A
- CRNX N/A
- 52 Week Low
- BDC $80.90
- CRNX $34.07
- 52 Week High
- BDC $131.82
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- BDC 38.98
- CRNX 42.29
- Support Level
- BDC $112.89
- CRNX $35.10
- Resistance Level
- BDC $116.11
- CRNX $35.85
- Average True Range (ATR)
- BDC 3.39
- CRNX 1.45
- MACD
- BDC -0.19
- CRNX 0.47
- Stochastic Oscillator
- BDC 36.59
- CRNX 49.78
About BDC Belden Inc
Belden Inc provides signal transmission products to distributors, end-users, installers, and original equipment manufacturers. The firm operates in two segments - Enterprise Solutions and Industrial Solutions. The Enterprise Solutions segment is a provider in network infrastructure solutions, as well as cabling and connectivity solutions for commercial audio/video and security applications. The Industrial Solutions segment is a provider of high-performance networking components and machine connectivity products. It operates in Americas, EMEA and APAC, out of which maximum revenue from Americas.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.